{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:56:16Z","timestamp":1768434976763,"version":"3.49.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/jcp.0b013e31829a876a","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T13:53:03Z","timestamp":1376574783000},"page":"636-642","source":"Crossref","is-referenced-by-count":29,"title":["Effects of Memantine on Clinical Ratings, Fluorodeoxyglucose Positron Emission Tomography Measurements, and Cerebrospinal Fluid Assays in Patients With Moderate to Severe Alzheimer Dementia"],"prefix":"10.1097","volume":"33","author":[{"given":"Tao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M.","family":"Reiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kewei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shifu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"1","key":"R1-8-20210128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archneur.63.1.49","article-title":"A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease.","volume":"63","author":"Reisberg","year":"2006","journal-title":"Arch Neurol"},{"issue":"1","key":"R2-8-20210128","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000102568","article-title":"Memantine in moderate to severe Alzheimers disease: a meta-analysis of randomised clinical trials.","volume":"24","author":"Winblad","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"13","key":"R3-8-20210128","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1038\/npp.2008.53","article-title":"Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimers disease.","volume":"33","author":"Dong","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"R4-8-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2217\/bmm.09.91","article-title":"Alzheimers prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible.","volume":"4","author":"Reiman","year":"2010","journal-title":"Biomark Med"},{"issue":"1","key":"R5-8-20210128","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/nimg.2002.1208","article-title":"Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.","volume":"17","author":"Herholz","year":"2002","journal-title":"Neuroimage"},{"key":"R6-8-20210128","first-page":"589","article-title":"Alzheimers prevention initiative: a plan to accelerate the evaluation of presymptomatic treatments. In: Ashford JW, Rosen A, Adamson M, et al. eds. Handbook of Imaging the Alzheimer Brain, Advances in Alzheimers Disease.","volume":"2","author":"Reiman","year":"2011","journal-title":"Amsterdam: IOS Press"},{"issue":"12","key":"R7-8-20210128","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/jnnp.2007.141648","article-title":"Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine.","volume":"79","author":"Schmidt","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"R8-8-20210128","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/JGP.0b013e3181ca3a4e","article-title":"Effects of memantine treatment on regional cortical metabolism in Alzheimers disease.","volume":"18","author":"Sultzer","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"issue":"7","key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"3","key":"R10-8-20210128","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0749-0690(18)30669-4","article-title":"Neuropsychological assessment of the severely impaired elderly patient.","volume":"5","author":"Saxton","year":"1989","journal-title":"Clin Geriatr Med"},{"issue":"3","key":"R11-8-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"11","key":"R12-8-20210128","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimers disease.","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"issue":"12","key":"R13-8-20210128","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"12","key":"R14-8-20210128","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","article-title":"Preclinical evidence of Alzheimers disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.","volume":"334","author":"Reiman","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"R15-8-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"issue":"2","key":"R16-8-20210128","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuroimage.2010.02.064","article-title":"Twelve-month metabolic declines in probable Alzheimers disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimers Disease Neuroimaging Initiative.","volume":"51","author":"Chen","year":"2010","journal-title":"Neuroimage"},{"issue":"4","key":"R17-8-20210128","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3233\/JAD-2010-100939","article-title":"A multicenter randomized proof of concept clinical trial applying 18FFDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimers disease.","volume":"22","author":"Tzimopoulou","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"R18-8-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-2008-13110","article-title":"Memantine treatment in patients with mild to moderate Alzheimers disease: results of a randomised, double-blind, placebo-controlled 6-month study.","volume":"13","author":"Bakchine","year":"2008","journal-title":"J Alzheimers Dis"},{"issue":"14","key":"R19-8-20210128","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimers disease.","volume":"348","author":"Reisberg","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"R20-8-20210128","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.neuroimage.2008.12.072","article-title":"Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimers Disease Neuroimaging Initiative (ADNI).","volume":"45","author":"Langbaum","year":"2009","journal-title":"Neuroimage"},{"issue":"2","key":"R21-8-20210128","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/156720509787602852","article-title":"AN1792 (QS-21)-251 study team: long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.","volume":"6","author":"Vellas","year":"2009","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"R22-8-20210128","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuroimage.2011.01.049","article-title":"Characterizing Alzheimers disease using a hypometabolic convergence index.","volume":"56","author":"Chen","year":"2011","journal-title":"Neuroimage"},{"key":"R23-8-20210128","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1176\/appi.ajp.159.5.738","article-title":"Longitudinal evaluation of cerebral metabolic decline in dementia: implications for using resting PET to measure outcome in long-term treatment studies of Alzheimers disease.","volume":"159","author":"Alexander","year":"2002","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e31829a876a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:01:58Z","timestamp":1620957718000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201310000-00008"}},"subtitle":["A 24-Week, Randomized, Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31829a876a","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}